loading
전일 마감가:
$3.88
열려 있는:
$3.8
하루 거래량:
2,332
Relative Volume:
0.10
시가총액:
$66.03M
수익:
-
순이익/손실:
$-12.63M
주가수익비율:
-5.2002
EPS:
-0.6942
순현금흐름:
$-12.18M
1주 성능:
-9.07%
1개월 성능:
-6.48%
6개월 성능:
-17.95%
1년 성능:
+9.07%
1일 변동 폭
Value
$3.61
$3.90
1주일 범위
Value
$3.61
$4.15
52주 변동 폭
Value
$2.20
$7.28

Genenta Science Spa Adr Stock (GNTA) Company Profile

Name
명칭
Genenta Science Spa Adr
Name
전화
-
Name
주소
-
Name
직원
13
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
GNTA's Discussions on Twitter

GNTA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GNTA
Genenta Science Spa Adr
3.61 66.03M 0 -12.63M -12.18M -0.6942
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-06-29 재개 ROTH MKM Buy
2022-07-25 개시 H.C. Wainwright Buy
2022-01-13 개시 Maxim Group Buy

Genenta Science Spa Adr 주식(GNTA)의 최신 뉴스

pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks

Mar 19, 2025
pulisher
Jan 10, 2025

Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance

Jan 10, 2025
pulisher
Jan 09, 2025

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewswire Inc.

Jan 09, 2025
pulisher
Dec 30, 2024

Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks

Dec 30, 2024
pulisher
Dec 20, 2024

Genenta Science Updates ATM Sales Agreement with New Agent - TipRanks

Dec 20, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading resumes - TipRanks

Nov 29, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading halted, volatility trading pause - TipRanks

Nov 29, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $30M To Consider - Yahoo Finance

Nov 13, 2024
pulisher
Oct 23, 2024

Genenta Science CEO to present at U.S. Senate meeting - TipRanks

Oct 23, 2024
pulisher
Oct 03, 2024

Genenta Science receives Buy rating amid trial approval - Investing.com

Oct 03, 2024
pulisher
Apr 02, 2024

Genenta Science Announces Shareholder Meeting - TipRanks

Apr 02, 2024
pulisher
Mar 26, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 26, 2024
pulisher
Mar 04, 2024

DHR Stock Quote Price and Forecast - CNN

Mar 04, 2024
pulisher
Jun 05, 2015

Danaher (DHR) Stock Price, News & Analysis - MarketBeat

Jun 05, 2015

Genenta Science Spa Adr (GNTA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):